Development of a vaccine based on bacteria‐mimicking tumor cells coated with novel engineered toll‐like receptor 2 ligands-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of a vaccine based on bacteria‐mimicking tumor cells coated with novel engineered toll‐like receptor 2 ligands

Published:2018-04-22 Issue:5 Volume:109 Page:1319-1329
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Akazawa Takashi¹^ORCID,Ohashi Toshimitsu¹²^ORCID,Wijewardana Viskam³,Sugiura Kikuya³,Inoue Norimitsu¹^ORCID

Affiliation:

1. Department of Tumor Immunology Research Center Osaka International Cancer Institute Osaka Japan

2. Department of Otolaryngology Gifu University Graduate School of Medicine Gifu City Japan

3. Department of Advanced Pathobiology Graduate School of Life and Environmental Sciences Osaka Prefecture University Izumisano, Osaka Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.13576

Reference54 articles.

1. Reversing T‐cell dysfunction and exhaustion in cancer;Zarour HM;Clin Cancer Res,1856

2. CTLA-4 and PD-1/PD-L1 Blockade: New Immunotherapeutic Modalities with Durable Clinical Benefit in Melanoma Patients

3. Myeloid-Derived Suppressor Cells

4. From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation

5. M2‐like macrophage polarization in high lactic acid‐producing head and neck cancer

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineered mitochondria exert potent antitumor immunity as a cancer vaccine platform;Cellular & Molecular Immunology;2024-08-20

2. Strategies to prevent, curb and eliminate biofilm formation based on the characteristics of various periods in one biofilm life cycle;Frontiers in Cellular and Infection Microbiology;2022-09-21

3. Recent research progress of biologically active peptides;BioFactors;2022-01-25

4. Traditional Chinese medicine and lung cancer——From theory to practice;Biomedicine & Pharmacotherapy;2021-05

5. TLRs as a Promise Target Along With Immune Checkpoint Against Gastric Cancer;Frontiers in Cell and Developmental Biology;2021-01-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3